Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 86,270 | 88,096 | 81,691 | 80,731 | 78,715 |
| Cost of Goods | 6,942 | 9,384 | 13,436 | 8,197 | 7,582 |
| Gross Profit | 79,328 | 78,712 | 68,255 | 72,534 | 71,133 |
| Operating Expenses | 117,906 | 121,424 | 102,531 | 133,344 | 147,054 |
| Operating Income | -37,636 | -42,328 | -33,840 | -60,613 | -75,339 |
| Interest Expense | 11,844 | 11,095 | 9,620 | 8,257 | 8,147 |
| Other Income | -3,739 | -16,656 | 14,197 | 7,624 | 2,035 |
| Pre-tax Income | -53,219 | -70,079 | -29,263 | -61,246 | -81,451 |
| Income Tax | -287 | -14,214 | 4,023 | 911 | 3,809 |
| Net Income Continuous | -52,932 | -55,865 | -33,286 | -62,157 | -85,260 |
| Net Income | $-52,932 | $-55,865 | $-33,286 | $-62,157 | $-85,260 |
| EPS Basic Total Ops | -0.18 | -0.19 | -0.12 | -0.21 | -0.30 |
| EPS Basic Continuous Ops | -0.18 | -0.19 | -0.12 | -0.21 | -0.30 |
| EPS Diluted Total Ops | -0.18 | -0.19 | -0.12 | -0.21 | -0.30 |
| EPS Diluted Continuous Ops | -0.18 | -0.19 | -0.12 | -0.21 | -0.30 |
| EBITDA(a) | $-35,712 | $-40,346 | $-31,886 | $-58,621 | $-73,291 |